Dose selection in phase I studies: why we should always go for the Most effective, J Clin Oncol, vol.26, issue.21, pp.3650-3652, 2008. ,
Dose selection in phase I studies: why we should always go for the top, J Clin Oncol, vol.26, issue.10, pp.1576-1584, 2008. ,
Phase I trials of molecularly targeted agents: should we pay more attention to late toxicities?, J Clin Oncol, vol.29, issue.13, pp.1728-1763, 2011. ,
Phase I studies of drug combinations, J Clin Oncol, vol.28, issue.30, pp.4545-4551, 2010. ,
How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patientreported symptoms from the quality-of-life questionnaire C30, J Clin Oncol, vol.22, issue.17, pp.3485-90, 2004. ,
Defining dose-limiting toxicity for phase 1 trials of molecularly targeted agents: results of a DLT-TARGETT international survey, Eur J Cancer, vol.50, issue.12, pp.2050-2056, 2014. ,
Patientreported tolerability of adverse events in phase 1 trials, ESMO Open, vol.2, issue.2, p.148, 2017. ,
Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial, Radiother Oncol, vol.87, issue.2, pp.181-188, 2008. ,
Phase I clinical and pharmacokinetic study of bi-weekly carboplatin/paclitaxel chemotherapy in elderly patients with advanced non-small cell lung cancer ,
, Anticancer Res, vol.33, issue.1, pp.261-267, 2013.
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), JNCI J Natl Cancer Inst, vol.106, issue.9, p.244, 2014. ,
An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma, BMJ Open, vol.6, issue.6, p.10696, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01384670
Statistical challenges in the analysis of health-related quality of life in Cancer clinical trials, J Clin Oncol, vol.34, issue.16, pp.1953-1959, 2016. ,
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards, Lancet Oncol, vol.17, issue.11, pp.510-514, 2016. ,
Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer, Cancer Prev Res, vol.5, issue.9, pp.1144-54, 2012. ,
Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma, Med Oncol, vol.29, issue.3, pp.1850-1858, 2012. ,
A phase i study of lapatinib with whole brain radiotherapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases, Breast Cancer Res Treat, vol.142, issue.2, pp.405-419, 2013. ,
A phase i study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin??) in cancer patients, Cancer Chemother Pharmacol, vol.71, issue.6, pp.1521-1551, 2013. ,
Phase I druginteraction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients, BMC Cancer, vol.13, issue.1, p.495, 2013. ,
Evaluation of sexuality, health-related quality-of-life and depression in advanced cancer patients: a prospective study in a phase i clinical trial unit of predominantly targeted anticancer drugs, Eur J Cancer, vol.49, issue.2, pp.431-439, 2013. ,
Phase i clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer, Cancer Chemother Pharmacol, vol.72, issue.1, pp.139-185, 2013. ,
Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme, J Neuro-Oncol, vol.121, issue.2, pp.319-348, 2015. ,
A phase I study of Veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid malignancies and peritoneal Carcinomatosis, Clin Cancer Res, vol.21, issue.1, pp.68-76, 2015. ,
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients, Cancer Immunol Immunother, vol.64, issue.9, pp.1159-73, 2015. ,
A phase i trial of mFOLFOX6 combined with the oral PI3K inhibitor BKM120 in patients with advanced refractory solid tumors, Investig New Drugs, vol.33, issue.6, pp.1225-1256, 2015. ,
Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate Cancer: a prospective phase 1 clinical trial, Eur Urol, vol.70, issue.3, pp.447-55, 2016. ,